Clinical Trial Update: Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial comparing intra-arterial versus intravenous cisplatin with radiation for oral cavity and oropharyngeal cancers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Cavity Cancer
• Oropharyngeal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Southern Illinois University | Conditions: Head and Neck Cancer | EARLY_Phase 1 | Status: TERMINATED